OpenAI Launches Biodefense Program for Public Health Agencies
OpenAI said the Rosalind Biodefense program will give vetted researchers, public health teams and mission-driven organizations access to GPT-Rosalind for defensive life sciences work.
Topics
News
- India-US Talks Put AI Stack In Focus
- OpenAI Plans Limited GPT-5.6 Rollout After White House Request
- Employers Still Want MBAs Even as One in Three Hands Entry-Level Work to AI
- AI Dispatch | Infosys Pitches AI Growth
- India May Take Minority Stake In Sarvam AI
- India Eases Satcom Rules by Dropping Sourcing Clause
OpenAI has launched a biodefense program to help vetted researchers, public health institutions and government partners use artificial intelligence to prepare for biological threats.
The program, called Rosalind Biodefense, will provide sponsored access to GPT-Rosalind, OpenAI’s life sciences model, and launch support for developers building defensive biosecurity applications, the company said.
OpenAI said the work will cover areas including epidemiological modeling, early detection, screening, preparedness, non-pharmaceutical interventions and other public health uses.
The company also said it is expanding trusted access to GPT-Rosalind for select US government and allied partners working on public health and biodefense missions.
Approved teams may use the model for early warning systems, diagnostics, outbreak response planning, preparedness, and medical countermeasure development.
The move comes as AI companies push deeper into scientific research and healthcare while facing scrutiny over the risks of advanced models in biology.
OpenAI said its approach includes trusted access, bio-specific capability assessments, expert red teaming, monitoring and security controls for higher-risk capabilities.
GPT-Rosalind was introduced in April as a research-preview model for biology, drug discovery and translational medicine. Reuters reported at the time that the model was designed to help researchers synthesize evidence, generate hypotheses, plan experiments and use scientific databases and tools.
“AI is accelerating progress across biology and the life sciences, creating new opportunities to advance scientific discovery, strengthen public health, and build resilience against biological threats,” OpenAI said in a statement.
OpenAI said the new program builds on its work with groups including the US Center for AI Standards and Innovation, the UK AI Security Institute, Los Alamos National Laboratory and the Frontier Model Forum.
Among the first organizations in the program is Fourth Eon Biosecurity, which is testing GPT-Rosalind for AI-native screening systems that analyze DNA sequences and generate threat assessments. OpenAI is also working with Lawrence Livermore National Laboratory on biodefense preparedness research.
The Rosalind Biodefense program is open to qualified applicants globally. OpenAI said it is seeking academic, nonprofit, government-affiliated, mission-driven firms and other qualified research teams working on projects with clear public benefit.

